Category: General Biotechnology

Latest Licensable Biotechnology Inventions

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents below for more details, or visit TechTransferWatch.com for more options. ETP1 and ETP2 regulate plant ethylene response Hong Qiao, Joseph R. Ecker Salk Institute for Biological Studies Patent number: 9,000,260 Issue Date: April 07, 2015 […]


Journal of Commercial Biotechnology New Issue Published

Journal of Commercial Biotechnology Labels, Lawyers, & Logic Peter J. Pitts America deserves access to high-quality health care without avoidable medical errors and complications. This achievable goal begins with harnessing and using the power of information. And that begins with clear, accurate, and usable labeling.The American health care system is undermined, underserved, and undervalued when […]


Latest Licensable Biotechnology Inventions

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents below for more details, or visit TechTransferWatch.com for more options. Production of spider silk protein in corn Anne W. Sylvester, Randolph V. Lewis, David Jackson University of Wyoming Patent number: 8,993,844 Issue Date: March 31, […]


Latest Licensable Biotechnology Inventions from TechTransferWatch.com

TechTransferWatch is a search engine and alert service for licenseable technologies from academic labs, foundations, and government. Click the patents below for more details, or visit TechTransferWatch.com for more options. Imaging and evaluating embryos, oocytes, and stem cells Stanford University Patent number: 8,989,475 Issue Date: March 24, 2015 Promoters and methods thereof Ju-Kon Kim, Su-Hyun […]


Expand Your Cell-Based Protein Manufacturing with Hollow Fiber Bioreactors

This is a guest post from Halina Zakowicz, Marketing Specialist at Biovest International, Inc. Do you have a response to Halina’s post? Respond in the comments section below. Scaling up cell culture production can be a tricky proposition. Generating large amounts of cell-secreted proteins is labor-intensive when utilizing traditional cell culture methods. Quality and yields […]


Biotechnology in India: Public–private partnerships

Journal of Commercial Biotechnology
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Biotechnology in India: Public–private partnerships

Go to paper

ABSTRACT: As the purpose of this study was a survey of public sector–private industry collaborations of the biotechnology sector in India, an organisational and functional overview of this sector was needed. Therefore, rather than studying a hypothetical biotech sector in India, the focus of this work was to study the public–private partnerships (PPP) that are occurring in India in the area of modern biotechnology…

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website


Assessing the history and value of Human Genome Sciences

Journal of Commercial Biotechnology
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology

Assessing the history and value of Human Genome Sciences

Go to paper

ABSTRACT: Human Genome Science (HGS) aspired to dominate the emergent field of genomics by discovering expressed gene sequences and developing therapeutic and diagnostic products based on proprietary genes. While HGS’ accomplishments fell short of their own lofty expectations, by the time HGS was acquired by GlaxoSmithKline, the company had extensive intellectual property and had launched a product with >$1 billion market potential…

The Journal of Commercial Biotechnology is a unique forum for all those involved in biotechnology commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast moving field.

Each issue publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as:

  • Management
  • Policy
  • Finance
  • Law
  • Regulation
  • Bioethics

For more information, see the Journal of Commercial Biotechnology website


Social Network Analysis of Pharmaceutical Innovation

I was just notified of a fascinating paper citing my research from DrugPatentWatch.com. Briefly, I found two surprising results: Firstly, pharmaceutical innovation has been essentially immobile — it remains almost completely rooted in the United States and Western Europe. Secondly, there is virtually no innovation coming out of so-called emerging economies such as India and China (i.e. <1% as […]


Biotechnology in Countries Starting with “I” – Part 7: India

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. For the next chapter in this continuing series, let’s turn back to India and the draft National IPR Policy currently under debate in New Delhi. A great deal […]